Activity Title

Advanced Heart Failure Therapies: Who, When, & What

Program Goals

Of the more than 6 million Americans living with heart failure approximately 10% have advanced heart failure or Stage D Heart Failure.  Patients in this category should be evaluated for advanced therapy options including heart transplant and LVAD therapy. This educational activity will focus on the identification of patients with Stage D Heart Failure utilizing basic variables from history, lab data, imaging, physical exam, and current regimen.

Target Audience

Cardiologists; Critical Care Specialists; Internal Medicine and Primary Care Physicians; Physician Assistants; Advanced Practice Nurses; and Nurse Practitioners. 

Learning Objectives

After the conclusion of this activity, participants should be able to:
1. Describe the prevalence and risk factors for heart failure in general and Stage D Heart Failure specifically.
2. Identify patients in Stage D Heart Failure utilizing basic variables from history, lab data, imaging, physical exam, and current medical regimen.
3. Discuss the options available like Heart Transplant, LVAD, Milrinone as palliative therapy and the outcomes associated with each.

Faculty

Eman Hamad, MD, MHA, FACC, FHFSA, FAHA
Director, Advanced Heart Failure & Transplant Program
Director, Cardio-Oncology Program
Medical Director, Mechanical Circulatory Support Program
Program Director, Heart Failure & Transplant Fellowship
Temple Heart & Vascular Institute
Philadelphia, PA

Educational Activity Agenda

Educational Presentation (51 minutes)
Post Test, Evaluation & Certificate delivery (10 minutes)
Total Activity: (61 minutes)

Release and Expiration Dates

Release Date: April 4, 2025
Expiration Date: April 4, 2027

Disclosure Policy

It is the policy of the Lewis Katz School of Medicine at Temple University, The Albert J. Finestone, M.D., Office for Continuing Medical Education that anyone in a position to control the content of a certified educational activity must disclose any financial relationships with ineligible companies within the prior 24 months. The Accreditation Council for Continuing Medical Education (ACCME) defines ineligible companies as “those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.” Speakers must also disclose discussions of unlabeled/unapproved uses of drugs or devices during their presentations. The Lewis Katz School of Medicine at Temple University has policies in place that will identify and mitigate all conflicts of interest prior to the educational activity. Detailed disclosure will be communicated to learners prior to the activity.

Faculty Disclosures

The faculty disclosed the following financial relationships with ineligible companies related to the content of this educational activity. 

Eman Hamad, MD, MHA, FACC, FHFSA, FAHA
• Nothing to disclose

None of the faculty for this educational activity have relevant financial relationships to disclose with ineligible companies.

Course Directors, Planners, Reviewers, and Managers/CME Staff Disclosures

The course directors, planners, reviewers, and managers/CME staff disclosed the following financial relationships with ineligible companies related to the content of this educational activity:

Eman Hamad, MD, MHA, FACC, FHFSA, FAHA   (Planner and Faculty)
• Nothing to disclose

Val Rakita, MD (Reviewer)
• Nothing to disclose

Arnold I. Meyer, Ed.D, FACEHP (Planner and CME Staff)
• Nothing to disclose

Katrina Ilagan (CME Staff) 
• Nothing to disclose

Accreditation Statement

Lewis Katz School of Medicine at Temple University is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide Continuing Medical Education for physicians.

Certification Statement

Lewis Katz School of Medicine at Temple University designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

How to Obtain CME Credit

Attendees are expected to view all presentations before attempting to take the test and/or complete the activity evaluation. Successful completion will lead to the issuance of a certificate for AMA PRA Category 1 Credit(s)™.  To receive credit, the course must be completed between April 4, 2025 - April 4, 2027. 

Participation in this activity should be completed in approximately 1.0 hour(s). Please follow these steps in order to receive CME/CE credit for viewing the webcast:

• Read all of the CME/CE accreditation information above.
• View the complete electronic (web) activity.
• Click on the link to apply for CME/CE credits.
• Complete the online registration (registration is free).
• Complete the online test and/or evaluation. Participants must receive a test score of at least 75% and answer all evaluation questions to receive a certificate.

After successfully completing the online test and/or evaluation, your application will be immediately processed, and you will be given the opportunity to download a personalized CME/CE certificate for participation in this activity.

Should you have any CME questions regarding this activity, please contact:

The Albert J. Finestone, MD Office for Continuing Medical Education
Lewis Katz School of Medicine at Temple University
3500 North Broad Street
11th Floor MERB, Room 1111S
Philadelphia, PA 19140
Main CME Phone:  215-707-4787
Fax:  215-707-8268

Click here to view the web conference

Commercial Support Statement

No commercial support has been provided for this activity.

System Requirements

To view this educational activity you, will need a web browser with JavaScript and either Flash or HTML5 enabled.  Nearly all modern web browsers will work. 

  If you have special accommodations that we can address to make your participation more meaningful and enjoyable, please contact our office at (215) 707-4787 or cme@temple.edu.

Copyright

Copyright©. Temple University. Philadelphia, PA. All rights reserved.